Cite

HARVARD Citation

    Cappuzzo, F. et al. (n.d.). Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus. Lung cancer. 87 (2), pp. 89-95. [Online]. 
  
Back to record